← Back to Search

Other

Tattoo machine (SOL Nova Device) for Alopecia Areata

N/A
Waitlist Available
Led By Brett King, MD, PhD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will test if a new device that causes micro-injuries to the skin can help hair growth in people with alopecia areata who haven't responded well to other treatments.

Eligible Conditions
  • Alopecia Areata

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Target area hair count (TAHC)
Secondary outcome measures
Hair phase
Terminal hairs
Vellus hairs

Trial Design

1Treatment groups
Experimental Treatment
Group I: MicroneedlingExperimental Treatment1 Intervention
Participants with Alopecia Areata will receive microneedling with a tattoo machine.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tattoo machine (SOL Nova Device)
2021
N/A
~10

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,853 Previous Clinical Trials
2,738,556 Total Patients Enrolled
5 Trials studying Alopecia Areata
74 Patients Enrolled for Alopecia Areata
Brett King, MD, PhDPrincipal InvestigatorAssociate Professor of Dermatology, Yale University
4 Previous Clinical Trials
24 Total Patients Enrolled
3 Trials studying Alopecia Areata
24 Patients Enrolled for Alopecia Areata

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still space available to join this research endeavor?

"Clinicialtrials.gov's records state that this particular medical trial, which was initially published on April 9th 2021 and last updated on July 9th 2022, is not recruiting new patients at the moment. But there are 86 other clinical trials in progress currently open for enrollment."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling
2021. "Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04338295.
~1 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top